文献速递头颈部肿瘤放疗

人乳头瘤病毒(HPV)时代下不明原发头颈癌的放射治疗:不必再砍树摘苹果

Management of unknown primary head and neck cancer with radiation therapy in the era of human papillomavirus (HPV): No longer cutting down the tree to get an apple.
PubMed 文献 · Radiother Oncol · 2023-10-14

本综述依据PRISMA-P声明检索2002年1月至2023年1月PubMed英文文献,分析放射治疗用于以颈部淋巴结转移为首发表现的原发灶不明头颈鳞癌。调强放疗、正电子发射断层扫描、免疫组化生物标志物检测及经口机器人手术等进展已改变该病处理方式,但放疗照射方式仍存争议,特别是是否仍需沿用双侧颈部及全咽轴全面照射的旧标准。前瞻性证据缺乏,现有研究受样本量有限及检查、治疗、纳入标准和随访异质性影响。

要点

  • 调强放疗、PET、免疫组化及经口机器人手术等进展已改变原发灶不明头颈鳞癌的处理方式。
  • 是否仍需沿用双侧颈部及全咽轴全面照射以覆盖所有可能黏膜病变部位,仍存争议。
  • 前瞻性证据缺乏,现有研究受样本量有限及检查、治疗、纳入标准与随访异质性影响。

核心结论

  • 前瞻性证据缺乏,现有研究受样本量相对有限以及检查、治疗、纳入标准和随访变异等因素影响而变得复杂。
  • 科学技术的进步带来了高度定制化的更精确方法,尤其考虑到人乳头瘤病毒相关疾病患者比例增加。

研究设计与样本

  • 本研究为系统综述,设计基于系统综述和荟萃分析优先报告条目方案(PRISMA-P)声明。
  • 检索2002年1月至2023年1月PubMed上可获取全文、限英文、以人为研究对象的同行评议文献,并审查所纳入文献的完整参考文献目录以剔除无关研究。

主要发现

  • 调强放疗、正电子发射断层扫描、免疫组化生物标志物检测及经口机器人手术等微创手术技术等突破,近几十年来已从根本上改变了该病的处理方式。
  • 尽管头颈原发灶不明癌发病率相对较低,关于是否必须采用靶向双侧颈部及全咽轴的旧标准方法进行全面放疗以覆盖所有可能黏膜病变部位的问题持续存在。
  • 放疗实施方式方面仍存在争议。

局限性

  • 前瞻性证据缺乏。
  • 现有研究受样本量相对有限的影响。
  • 现有研究受检查、治疗、纳入标准和随访变异的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Given the central role that radiation has in the management of head and neck squamous cell carcinoma of unknown primary origin, it is imperative to review how treatment paradigms have been refined and continue to evolve in the modern era. METHODS AND MATERIALS: This study was designed based on the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) statement. A literature search of peer-reviewed publications was undertaken to identify works pertaining to the use of radiation for squamous cell carcinoma of unknown primary origin presenting as cervical lymph node metastases. Articles published from January 2002 to January 2023 with full text available on PubMed and restricted to the English language and human subjects were included. The full bibliographies of identified articles were reviewed and irrelevant studies were removed. RESULTS: While such breakthroughs as intensity-modulated radiotherapy, positron emission tomography, biomarker testing with immune-histochemistry, and minimally invasive surgical techniques such as transoral robotic surgery have fundamentally changed the approach to this disease in recent decades, controversies still exist with respect to the manner in which radiation is delivered. Although the incidence of head and neck unknown primary cancer is relatively low, questions regarding the necessity of comprehensive radiation using the age-old standard method of targeting the bilateral necks and entire pharyngeal axis to encompass all putative sites of mucosal disease persist. CONCLUSIONS: Prospective evidence is lacking, and the available studies have been complicated by such factors as the relatively limited sample sizes, as well as the variability in work-up, treatment, inclusion criteria, and follow-up. Regardless, advances in science and technology have ushered in more precise approaches with a high degree of customization, particularly given the increased proportion of patients presenting with human papillomavirus-related disease.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Chen AM. Management of unknown primary head and neck cancer with radiation therapy in the era of human papillomavirus (HPV): No longer cutting down the tree to get an apple. Radiother Oncol. 2023. PMID: 37844736. doi:10.1016/j.radonc.2023.109952

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。